These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17587842)

  • 1. Imiquimod 5% cream for the prevention of recurrence after excision of presternal keloids.
    Malhotra AK; Gupta S; Khaitan BK; Sharma VK
    Dermatology; 2007; 215(1):63-5. PubMed ID: 17587842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of keloid scars post-shave excision with imiquimod 5% cream: A prospective, double-blind, placebo-controlled pilot study.
    Berman B; Harrison-Balestra C; Perez OA; Viera M; Villa A; Zell D; Ramirez C
    J Drugs Dermatol; 2009 May; 8(5):455-8. PubMed ID: 19537368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids.
    Cação FM; Tanaka V; Messina MC
    Dermatol Surg; 2009 Apr; 35(4):629-33. PubMed ID: 19415792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study.
    Martin-García RF; Busquets AC
    Dermatol Surg; 2005 Nov; 31(11 Pt 1):1394-8. PubMed ID: 16416606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of earlobe keloids with imiquimod after tangential shave excision.
    Stashower ME
    Dermatol Surg; 2006 Mar; 32(3):380-6. PubMed ID: 16640683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids.
    Chuangsuwanich A; Gunjittisomram S
    J Med Assoc Thai; 2007 Jul; 90(7):1363-7. PubMed ID: 17710978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot study of the effect of postoperative imiquimod 5% cream on the recurrence rate of excised keloids.
    Berman B; Kaufman J
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S209-11. PubMed ID: 12271279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod 5% cream for keloid management.
    Berman B; Villa A
    Dermatol Surg; 2003 Oct; 29(10):1050-1. PubMed ID: 12974703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 2 Representative Topical Agents to Prevent Keloid Recurrence After Surgical Excision.
    Shin JY; Yun SK; Roh SG; Lee NH; Yang KM
    J Oral Maxillofac Surg; 2017 Feb; 75(2):401.e1-401.e6. PubMed ID: 27865791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experience with keloids after excision and application of 5% imiquimod cream.
    Patel PJ; Skinner RB
    Dermatol Surg; 2006 Mar; 32(3):462. PubMed ID: 16640700
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis.
    Jacob SE; Berman B; Nassiri M; Vincek V
    Br J Dermatol; 2003 Nov; 149 Suppl 66():62-5. PubMed ID: 14616355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.
    Korman N; Moy R; Ling M; Matheson R; Smith S; McKane S; Lee JH
    Arch Dermatol; 2005 Apr; 141(4):467-73. PubMed ID: 15837864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imiquimod to prevent keloid recurrence postexcision: A systematic review and meta-analysis.
    Klotz T; Munn Z; Aromataris EC; Greenwood JE
    Wound Repair Regen; 2020 Jan; 28(1):145-156. PubMed ID: 31587416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapies for the management of keloids.
    Poochareon VN; Berman B
    J Craniofac Surg; 2003 Sep; 14(5):654-7. PubMed ID: 14501323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention and treatment of keloids with intralesional verapamil.
    D'Andrea F; Brongo S; Ferraro G; Baroni A
    Dermatology; 2002; 204(1):60-2. PubMed ID: 11834852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical mitomycin C in the prevention of keloid scar recurrence.
    Sanders KW; Gage-White L; Stucker FJ
    Arch Facial Plast Surg; 2005; 7(3):172-5. PubMed ID: 15897406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of topical imiquimod 5% cream in the management of chronic radiation dermatitis with multiple neoplasias.
    Sachse MM; Zimmermann J; Bahmer FA
    Eur J Dermatol; 2006; 16(1):56-8. PubMed ID: 16436343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porokeratosis of Mibelli: successful treatment with topical 5% imiquimod cream.
    Harrison S; Sinclair R
    Australas J Dermatol; 2003 Nov; 44(4):281-3. PubMed ID: 14616497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granuloma annulare: dramatically altered appearance after application of 5% imiquimod cream.
    Stephenson S; Nedorost S
    Pediatr Dermatol; 2008; 25(1):138-9. PubMed ID: 18304183
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.